Search

Your search keyword '"ANTIPSYCHOTIC agents"' showing total 98,783 results

Search Constraints

Start Over You searched for: Descriptor "ANTIPSYCHOTIC agents" Remove constraint Descriptor: "ANTIPSYCHOTIC agents"
98,783 results on '"ANTIPSYCHOTIC agents"'

Search Results

17. Effectiveness of antipsychotic drug therapy for treating psychosis in people with epilepsy: A systematic review.

18. Exposure‐Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM.

19. Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis.

20. The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two‐cohort study among patients with first‐episode schizophrenia.

21. Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study.

22. The Relationship Between Antipsychotics, Cognitive Enhancers, and Major Adverse Cardiovascular/Cerebrovascular Events (MACCE) in Older Adults with Behavioral and Psychological Symptoms of Dementia.

23. Adherence Rates and Barriers to Second-Generation Antipsychotic Medication Use in Youth with Bipolar Spectrum Disorders Who Have Overweight/Obesity.

24. Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of Dementia.

25. Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients.

27. Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.

28. Evaluation of Prescription Patterns in Management of Agitation in Patients Referred to the Emergency Department.

29. Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety.

30. Research Letter: Dispensing of psychotropic medications in Australia between 2013 and 2022.

31. Antipsychotic medications and severe sepsis in schizophrenia: A nested case–control study.

32. Exposure–Response Modeling in Adults and Adolescents With Schizophrenia to Support the Extrapolation of Brexpiprazole Efficacy to Adolescents.

33. Evaluation of the Impact of the Addition of Atypical Antipsychotics to Continuous Infusion Propofol Therapy.

34. Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis.

35. The impact of COVID-19 public health measures on the utilization of antipsychotics in schizophrenia in Manitoba – A population-based study.

36. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data.

37. Analysis identifies factors associated with response to ketamine for TRD.

38. Factors associated with suicide risk among Brazilian graduate students during the COVID-19 pandemic.

39. Improving the release rate of lurasidone hydrochloride from fast disintegrating tablets using green solvent evaporation technique.

40. A Closer Look at Antipsychotic Adverse Effects: Investigating Anticholinergic Toxidrome Induced by Olanzapine Overdose.

41. بررسی تأثیرات دونپزیل بر روی علایم بالینی و مهارتهای زبانی و اجرایی در افراد مبتلا به طیف اوتیسم یک مرور نظام مند.

42. Risk factors and risk stratification approaches for delirium screening: A Geriatric Emergency Department Guidelines 2.0 systematic review.

43. Health Care Team Interventions to Reduce Distress Behaviors in Older Adults: A Systematic Review.

44. Nursing Home Characteristics Associated with Antipsychotic Prescribing After Implementation of the National Antipsychotic Reduction Initiative (ARI).

45. Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia.

46. Dysphagia in schizophrenia: pathological mechanisms and treatment recommendations.

47. The cognitive effects of stopping and starting antipsychotics on changes in cognitive functioning.

48. Aberrant glycosylation in schizophrenia: insights into pathophysiological mechanisms and therapeutic potentials.

49. Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder.

50. Clinical challenges in the dosing and titration of cariprazine.

Catalog

Books, media, physical & digital resources